iTeos Therapeutics, Inc. (ITOS) Dividend History

iTeos Therapeutics, Inc. (ITOS) is a clinical-stage immuno-oncology company focused on developing innovative cancer therapies that modulate the immune system. The company's pipeline includes novel antibodies aimed at enhancing the body's ability to recognize and attack tumors, with a focus on addressing unmet needs in cancer treatment. iTeos is committed to advancing therapies that improve patient outcomes through targeted immune modulation.

321 Arsenal Street, Watertown, MA, 02472
Phone: 857-204-4583
Website:

Dividend History

iTeos Therapeutics, Inc. currently does not pay dividends

Company News

Dividend data last updated 06/07/2025 04:45:25 UTC